Risk factors for the development of oedema and lymphoedema

British Journal of Nursing : BJN
M Woods

Abstract

An important symptom of ill health in clinical medicine is the development of oedema, which represents an imbalance in the amount of fluid entering and leaving the tissues of the body. Although medical treatment for the underlying cause of oedema is required, in both cancer and non-cancer settings risk factors that may increase or decrease the potential for oedema to develop or worsen can be identified. For the patient who has risk factors for the development of oedema, advice and education can enable the risk to be modified. Reducing the risk of oedema formation will help avoid long-term problematic oedema and complex skin conditions, as well as maintaining the patient's quality of life. This article discusses some of the risk factors for oedema and lymphoedema and concludes with an outline of how the risk can be managed.

References

Jun 27, 2007·Annals of Surgery·Anand D PurushothamStephen W Duffy
Jun 30, 2007·Journal of Vascular Surgery·Michael H CriquiArnost Fronek
Apr 3, 2013·Journal of Vascular Surgery·Joann M Lohr, Ruth L Bush
Jan 15, 2014·International Journal of Radiation Oncology, Biology, Physics·Laura E G WarrenAlphonse G Taghian
Feb 19, 2014·The British Journal of Surgery·H SackeyJ Frisell
Aug 3, 2014·QJM : Monthly Journal of the Association of Physicians·E O'MalleyD O'Shea
Nov 21, 2014·CA: a Cancer Journal for Clinicians·Simona F ShaitelmanJanice N Cormier
Oct 6, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Bárbara Reis WarissAnke Bergmann
Jan 28, 2017·The Breast : Official Journal of the European Society of Mastology·Navid Mohamadpour ToyserkaniJens Ahm Sørensen
Sep 4, 2018·Gland Surgery·Tessa C GillespieAlphonse G Taghian

❮ Previous
Next ❯

Citations

Jan 10, 2020·British Journal of Nursing : BJN·Aby Mitchell, Scott Elbourne

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Medical Journal
G W TAYLORW G DANGERFIELD
Clinical Medicine : Journal of the Royal College of Physicians of London
Suzanne Kite, Fiona Hicks
Revue de l'infirmière
Anna Kocher, Évelyne Lavaux-Barriac
© 2022 Meta ULC. All rights reserved